New Delhi: The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) for clinical trials of Covid-19 vaccine.
BBIL is using the virus strain isolated at ICMR’s National Institute of Virology (NIV) in Pune to develop the vaccine. The clinical trials will be held in 12 institutes across the country.
The ICMR has asked these institutes to fast-track clinical trials of the vaccine as it is being considered as one of the “top priority projects” which are being “monitored at the topmost level of the government”.
Discussion about this post